Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen-Specific Tolerance That Can Prevent GVHD Lethality In Vivo
Matthew J. O’Shaughnessy(Memorial Sloan Kettering Cancer Center), Bruce R. Blazar(University of Minnesota Medical Center), Thomas Grader‐Beck(Johns Hopkins University), Angela Panoskaltsis‐Mortari(University of Minnesota), Christine Vogtenhuber(University of Minnesota), Patricia A. Taylor(University of Minnesota), Ed Palmer(Versiti Blood Center of Wisconsin), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Zong-Ming Chen(San Raffaele University of Rome), Irene Gramaglia(La Jolla Institute for Immunology)
Cited by 18
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k